Navigation Links
Michael Garippa Joins SynCardia as President
Date:7/8/2010

Former CEO of TandemHeart to Champion Sales, Clinical Support, Training and Marketing for World’s Only Approved Total Artificial Heart

(Vocus) July 8, 2010 -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Michael Garippa, the CEO and President of TandemHeart for the last 8 years, has left the company to become SynCardia’s new president. Rodger Ford will continue as SynCardia’s CEO, concentrating on business development, while Mr. Garippa focuses on sales, clinical support, training and marketing.

“Now that the Freedom™ portable driver is undergoing an FDA IDE clinical study in the U.S. and has received CE approval for use in Europe, stable Total Artificial Heart patients* are able to wait for a matching donor heart at home,” said Ford. “Michael’s experience will provide the launching pad SynCardia needs to serve more of the world’s top transplant centers and their patients.”

Mr. Garippa was recruited by TandemHeart in 2002 as a turnaround expert and stayed on as CEO and President. He took the company from an R&D firm that had lost an aggregate of $50 million and had no commercial sales to a successful company with over $6 million in net income in the past 24 months. The TandemHeart, which provides short-term extracorporeal circulatory support, is currently being used in more than 125 of the top cardiac centers in the U.S. as recognized by U.S. News & World Report.

“The Total Artificial Heart has no equal,” said Mr. Garippa. “It is the only FDA, Health Canada and CE approved Total Artificial Heart in the world. There is no other approved device that provides biventricular replacement for patients with both sides of their heart failing.

“SynCardia already serves 30 of the top transplant centers in the world, with an additional 22 centers currently undergoing SynCardia certification training. The Freedom portable driver has provided us with the opportunity to train additional transplant centers in the U.S., Europe and Australia/New Zealand.”

Prior to joining TandemHeart, Mr. Garippa served as CEO and President of Gateway HomeCare. In addition, Mr. Garippa was Founder and CEO of Millennium HomeCare and The Prompt Care Companies. His background also includes being National Sales Manager at Omni Medical and Senior Analyst with the NYC Health and Hospitals Corporation. Mr. Garippa has a master’s degree from New York University and a Bachelor of Arts degree from Rutgers University.

*Through the IDE clinical study, stable Total Artificial Heart patients who meet study criteria may have the option to be discharged from the hospital with the Freedom portable driver, to wait for their matching donor heart at home and in their communities.

###

About SynCardia Systems, Inc.

SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 190 patient years of life on the device.

Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles.

Sign-up to receive the latest news updates from SynCardia
For additional information, please visit: syncardia.com
or follow SynCardia on Twitter – @SynCardia_News

Media Contact:
Don Isaacs
Vice President of Communications
SynCardia Systems, Inc.
Cell: (520) 955-0660
disaacs(at)syncardia(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/michael-garippa/prweb4236224.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
2. SoluBest Appoints Michael Sheckler, MBA, as CEO
3. Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinsons Disease
4. Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University
5. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
6. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
7. LCA-Vision Names Michael J. Celebrezze CFO
8. Xceleron Names Michael Butler as President & CEO
9. You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decades Real Nutritional Heroes
10. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
11. BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Michael Garippa Joins SynCardia as President
(Date:3/23/2017)... ... March 23, 2017 , ... ... selected by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® ... annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in ...
(Date:3/23/2017)... YORK , March 23, 2017 ... look at four equities in the Biotech industry: Sangamo ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics ... 21 st , 2017, Credit Suisse upgraded its rating on ... by downloading their free report at: ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... 2017 MarketNewsUpdates.com News Commentary  ... The traditional ways ... pressured as of late due to the rise of the ... a dramatic impact on patient,s quality of life as Biotech ... identifying new forms of opioid formulations that prevent abuse. Biotech ...
Breaking Biology Technology:
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):